Eicosis Human Health Inc.

This early-stage study tests whether a new drug called EC5026 is safe and can reduce nerve pain in people with spinal cord injury. About 36 adults with pain from traumatic or non-traumatic spinal cord injury will take either the drug or a placebo daily for 14 days. Researchers wi…

This early-stage trial tests whether an oral drug called EC5026 is safe and might ease symptoms in 18 adults with Parkinson's disease. Participants take the drug or a placebo daily for 28 days, with frequent checkups and tests. The main goal is safety, with symptom improvement ex…

This Phase 1 trial investigates how a single 8 mg dose of EC5026 is processed by the body in adults aged 55 and older with chronic kidney disease (stages 3b to 5, not on dialysis) compared to healthy adults with normal kidney function. Researchers will measure drug levels in bloo…